813 related articles for article (PubMed ID: 12237787)
1. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.
Riemann D; Voderholzer U; Cohrs S; Rodenbeck A; Hajak G; Rüther E; Wiegand MH; Laakmann G; Baghai T; Fischer W; Hoffmann M; Hohagen F; Mayer G; Berger M
Pharmacopsychiatry; 2002 Sep; 35(5):165-74. PubMed ID: 12237787
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of trimipramine and fluoxetine on sleep in geriatric depression.
Wolf R; Dykierek P; Gattaz WF; Maras A; Kohnen R; Dittmann RW; Geuppert M; Riemann D; Berger M
Pharmacopsychiatry; 2001 Mar; 34(2):60-5. PubMed ID: 11302565
[TBL] [Abstract][Full Text] [Related]
4. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality.
Donath F; Quispe S; Diefenbach K; Maurer A; Fietze I; Roots I
Pharmacopsychiatry; 2000 Mar; 33(2):47-53. PubMed ID: 10761819
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of lormetazepam and flurazepam in the treatment of insomnia.
Melo de Paula AJ
Clin Ther; 1984; 6(4):500-8. PubMed ID: 6380724
[TBL] [Abstract][Full Text] [Related]
6. Effects of zolpidem on cyclic alternating pattern, an objective marker of sleep instability, in Japanese patients with psychophysiological insomnia: a randomized crossover comparative study with placebo.
Ozone M; Yagi T; Itoh H; Tamura Y; Inoue Y; Uchimura N; Sasaki M; Shimizu T; Terzano MG; Parrino L
Pharmacopsychiatry; 2008 May; 41(3):106-14. PubMed ID: 18484552
[TBL] [Abstract][Full Text] [Related]
7. [Lormetazepam and amobarbital in the treatment of insomnia in psychiatric outpatients. A controlled study].
Ansseau M; Diricq S
Acta Psychiatr Belg; 1981; 81(6):580-94. PubMed ID: 6125088
[TBL] [Abstract][Full Text] [Related]
8. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
[TBL] [Abstract][Full Text] [Related]
9. Polysomnographic effects of adjuvant ginkgo biloba therapy in patients with major depression medicated with trimipramine.
Hemmeter U; Annen B; Bischof R; Brüderlin U; Hatzinger M; Rose U; Holsboer-Trachsler E
Pharmacopsychiatry; 2001 Mar; 34(2):50-9. PubMed ID: 11302564
[TBL] [Abstract][Full Text] [Related]
10. Lormetazepam and amobarbital sodium in the outpatient treatment of insomnia: a controlled trial.
Ansseau M; Diricq S
Clin Ther; 1983; 5(4):365-76. PubMed ID: 6135507
[TBL] [Abstract][Full Text] [Related]
11. Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression.
Sonntag A; Rothe B; Guldner J; Yassouridis A; Holsboer F; Steiger A
Depression; 1996; 4(1):1-13. PubMed ID: 9160649
[TBL] [Abstract][Full Text] [Related]
12. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
Scharf MB; Roth T; Vogel GW; Walsh JK
J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
[TBL] [Abstract][Full Text] [Related]
13. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
Walsh JK; Salkeld L; Knowles LJ; Tasker T; Hunneyball IM
Sleep Med; 2010 Jan; 11(1):23-30. PubMed ID: 19945340
[TBL] [Abstract][Full Text] [Related]
14. Treatment of primary insomnia with trimipramine: an alternative to benzodiazepine hypnotics?
Hohagen F; Montero RF; Weiss E; Lis S; Schönbrunn E; Dressing H; Riemann D; Berger M
Eur Arch Psychiatry Clin Neurosci; 1994; 244(2):65-72. PubMed ID: 7948056
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial.
Lydiard RB; Lankford DA; Seiden DJ; Landin R; Farber R; Walsh JK
J Clin Sleep Med; 2006 Jul; 2(3):309-15. PubMed ID: 17561543
[TBL] [Abstract][Full Text] [Related]
16. Nefazodone in primary insomnia: an open pilot study.
Wiegand MH; Galanakis P; Schreiner R
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1071-8. PubMed ID: 15610919
[TBL] [Abstract][Full Text] [Related]
17. The effect of placebo administration on the first-night effect in healthy young volunteers.
Suetsugi M; Mizuki Y; Yamamoto K; Uchida S; Watanabe Y
Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):839-47. PubMed ID: 17328999
[TBL] [Abstract][Full Text] [Related]
18. A polysomnography study of eszopiclone in elderly patients with insomnia.
McCall WV; Erman M; Krystal AD; Rosenberg R; Scharf M; Zammit GK; Wessel T
Curr Med Res Opin; 2006 Sep; 22(9):1633-42. PubMed ID: 16968566
[TBL] [Abstract][Full Text] [Related]
19. Polysomnographic study of intermittent zolpidem treatment in primary sleep maintenance insomnia.
Parrino L; Smerieri A; Giglia F; Milioli G; De Paolis F; Terzano MG
Clin Neuropharmacol; 2008; 31(1):40-50. PubMed ID: 18303490
[TBL] [Abstract][Full Text] [Related]
20. Effects on sleep: a double-blind study comparing trimipramine to imipramine in depressed insomniac patients.
Ware JC; Brown FW; Moorad PJ; Pittard JT; Cobert B
Sleep; 1989 Dec; 12(6):537-49. PubMed ID: 2688037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
